Long and short QT syndrome

Herzschrittmachertherapie und Elektrophysiologie

Volumn 17, Issue 4, 2006, Pages 205-210

  Borchert, B ^a   Lawrenz, T ^a   Stellbrink, C ^a  

^a OWL University   (Germany)

Author keywords

Long QT syndrome; Molecular electrophysiology; Primary electrical heart disease; Short QT syndrome; Sudden cardiac death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ION CHANNEL; QUINIDINE;

CHANNELOPATHY; DEFIBRILLATOR; ELECTROCARDIOGRAM; GANGLIONECTOMY; GENETIC DISORDER; GENETIC HETEROGENEITY; GENOTYPE; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MOLECULAR GENETICS; PHENOTYPE; QT INTERVAL; REVIEW; RISK; SHORT QT SYNDROME;

CHANNELOPATHIES; CHROMOSOME MAPPING; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; LONG QT SYNDROME; PHENOTYPE; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 33846205204     PISSN: 09387412     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00399-006-0534-9     Document Type: Review

References (36)

1. Splawski I, Shen J, Timothy KW, Vincent M, Keating MT et al (2000) Spectrum of mutations in long QT syndrome genes. Circulation 102:1178-1185
2. Moss AJ, Kass RS (2005) Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest 115:2018-2024
3. Kääb S, Schulze-Bahr E (2005) Susceptibility genes and modifiers for cardiac arrhythmias. Cardiovasc Res 67:397-413
4. Mohler PJ, Splawski I, Napolitano C, Timothy K, Priori S, Keating MT, Bennett V et al (2004) A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. PNAS 24:9137-9142
5. Plaster NM, Tawil R, Tristani-Firouzi M et al (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Anderson Syndrome. Cell 105:511-519
6. Tristani-Firouzi M, Jensen JL, Donaldson MR et al (2002) Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Anderson syndrome). J Clin Invest 110:381-388
7. Splawski I, Timothy KW, Sharpe LM et al (2004) Cav1.2 calcium channel dysfunction causes multisystem disorder including arrhythmia and autism. Cell 119:19-31
8. Priori S, Napolitano C, Vicentini A (2002) Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. J of Interv cardiac Electrophysiol 9:93-101
9. th anniversary of the international long QT syndrome registry. Circulation 111:1199-1201
10. Priori S, Schwartz PJ, Napolitano C, Capelletti D et al (2003) Risk stratification in the long QT syndrome. N Engl J Med 348:1866-1874
11. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Priori S, Keating MT, Hall WJ et al (1998) Influence of the genotype on the clinical course of the long QT syndrome. N Engl J Med 339:960-965
12. Vincent GM (2005) Risk assessment in long QT syndrome: the achilles heel of appropriate treatment. Heart Rhythm 2(5):505-506
13. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C et al (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Eur Heart J 27:2099-2140
14. Moss AJ, Zareba W, Kaufman E, Zang L, Wang Z et al (2002) Increased risk of arrhythmic events in long QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105:794-799
15. Rossenbacker T, Mubagwa K, Heidbüchel H, Carmeliet P et al (2005) Novel mutation in the per-arnt-sim domain of KCNH2 causes a malignant form of the long QT syndrome. Circulation 111:961-968
16. Westenkov P, Splawski I, Timothy K, Keating MT, Sanguinetti MC (2004) Compound mutations. A common cause of severe long QT syndrome. Circulation 109:1834-1841
17. Kimbrough J, Moss AJ, Zareba W, Robinson JL, Zhang L et al (2001) Clinical implications for affected parents and siblings of probands with long QT syndrome. Circulation 104:557-562
18. Priori S, Napolitano C, Schwartz PJ (1999) Low penetrance in the long QT syndrome. Circulation 99:529-533
19. Moss AJ, Zareba W, Hall WJ, Andrews ML et al (2000) Effectiveness and limitations of betablocker therapy in congenital long-QT syndrome. Circulation 101:616-623
20. Schwartz PJ, Priori S, Cerrone M, Zareba W, Epstein AE, Li C, Hu D et al (2004) Left cardiac sympathetic denervation in the management if high-risk patients affected by the long QT syndrome. Circulation 109:1826-1833
21. Dorostkar PC, Eldar M, Belhassen B, Scheinman MM (1999) Long-term follow-up of patients with long QT syndrome with betablocker and continuous pacing. Circulation 100:2431-2436
22. Mönnig G, Köbe J, Löher A, Eckardt L, Breithardt G, Schulze-Bahr E, Böcker D et al (2005) Implantable cardioverter- defibrillator therapy in patients with congenital long QT syndrome: a long term follow up. Heart Rhythm 2:497-504
23. Rajamani S, Anderson CL, Anson BD, January CT (2002) Pharmacological rescue of human K channel long QT2 mutations. Circulation 105:2830-2835
24. Gepstein L, Feld Y, Yankelson L (2004) Somatic gene and cell therapy strategies for the treatment of cardiac arrhythmias. Am J Physiol 286:H815-822
25. Phillips KA, Ackerman MJ, Sakowski J, Berul CI (2005) Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index cases. Heart Rhythm 2:1294-1300
26. Gussak I, Brugada P, Brugada J et al (2000) Idiopathic short QT interval: a new clinical syndrome? Cardiology 94:99-102
27. Brugada R, Hong K, Dumaine R, Brugada P, Antzelevitch C et al (2004) Sudden death associated with short QT syndrome linked to mutations in HERG. Circulation 109:30-35
28. Bellocq C, van Ginneken ACG, Bezzina CR, Wilde AA et al (2004) Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109:2394-2397
29. Priori S, Pandit SV, Rivolta I, Berenfeld O, Jalife J et al (2005) A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96:800-807
30. Schulze-Bahr E (2005) Short QT syndrome or Andersen syndrome. Yin and Yang of Kir2.1 channel dysfunction. Circ Res 96:703-704
31. Cerrone M, Noujaim S, Jalife J (2006) The short QT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation. J Intern Med 259:24-38
32. Schimpf R, Bauersfeld U, Gaita F, Wolpert C (2005) Short QT syndrome: successful prevention of sudden death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2:416-417
33. Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Haissaguerre M, Calo L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C (2004) Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 43:1494-1499
34. Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, Grossi S, Richardi E, Borggrefe M (2003) Short QT syndrome: a familial cause of sudden death. Circulation 108:965-970
35. Schimpf R, Wolpert C, Gaita F, Giustetto C, Borggrefe M (2005) Short QT syndrome. Cardiovasc Res 67(3):357-366
36. Brugada R, Hong K, Cordeiro JM, Dumaine R (2005) Short QT syndrome. CMAJ 173(11):1349-1354